Sheel Biotech Ltd (SHEEL) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Sheel Biotech Ltd reported sales of ₹22 Cr, operating profit of ₹2 Cr (OPM 8%) and net profit of ₹0 Cr for the quarter ended Sep 2025. Figures in ₹ crore, consolidated where available.
SHEEL quarterly results (₹ Cr) Metric Sep 2024 Sep 2025 Sales 11 22 Expenses 14 20 Operating Profit -2 2 OPM -22% 8% Other Income 0 0 Interest 1 1 Depreciation 0 1 Profit before tax -4 0 Tax 3% 24% Net Profit -4 0 EPS in Rs -2.53 0.13
SHEEL profit & loss, annual (₹ Cr) Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sales 63 84 89 103 110 Expenses 56 78 80 89 95 Operating Profit 7 6 9 14 15 OPM 10% 8% 10% 14% 14% Other Income 0 0 0 0 1 Interest 1 1 2 1 2 Depreciation 1 1 1 1 1 Profit before tax 5 5 6 12 13 Tax 0% 2% 20% 15% 17% Net Profit 5 5 5 10 11 EPS in Rs 11.58 10.88 12.26 25.27 7.12 Dividend Payout 0% 28% 25% 12% 14%
SHEEL balance sheet (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025 Equity Capital 4 4 4 15 15 Reserves 56 59 69 69 69 Borrowings 24 19 24 17 27 Other Liabilities 10 11 10 12 13 Total Liabilities 93 94 106 113 124 Fixed Assets 8 8 7 7 7 CWIP 0 0 0 0 0 Investments 1 1 1 1 1 Other Assets 84 85 98 105 116 Total Assets 93 94 106 113 124
SHEEL cash flows (₹ Cr) Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Cash from Operating Activity - 2 9 -1 9 Cash from Investing Activity - -2 -2 0 -2 Cash from Financing Activity - 0 -7 2 -7 Net Cash Flow - 0 0 0 0 Free Cash Flow - 1 8 -1 8 CFO/OP - 37% 105% 3% 75%
SHEEL ratios Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Debtor Days 352 280 230 204 182 Inventory Days 55 120 177 263 272 Days Payable 30 85 75 37 29 Cash Conversion Cycle 377 315 332 430 426 Working Capital Days 348 274 255 256 253 ROCE - 7% 10% 15% 14%